EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC 4.0

Reliability of Composite Autonomic Symptom Score (COMPASS)‐31 in Congenital Central Hypoventilation Syndrome

Benjamin Dudoignon, Plamen Bokov, Fatima Benterki, Nathalie Couque, Casey M Rand, Debra E Weese-Mayer, Christophe Delclaux

Pediatric Pulmonology · 2025

DOI: 10.1002/ppul.71072 ↗

At a glance

Journal article in Pediatric Pulmonology, 2025. Written by Benjamin Dudoignon and 6 co-authors. Institution: Service de Physiologie Pédiatrique -Centre du Sommeil - CRMR Hypoventilations alvéolaires rares, AP-HP, Hôpital Robert Debré, INSERM NeuroDiderot, Un…. Major MEDLINE topics: Sleep Apnea, Central, Hypoventilation, Autonomic Nervous System Diseases, Autonomic Nervous System. Cited 7 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: The authors received no specific funding for this study..

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Rationale

Congenital central hypoventilation syndrome (CCHS) is a rare disorder characterized by alveolar hypoventilation and variable autonomic nervous system (ANS) dysfunction (ANSD) due to mutations in PHOX2B , a gene crucial for ANS neural crest lineage differentiation. Objectives and Methods Our prospective study aims were twofold: to (1) assess the relationships between the subjective Composite Autonomic Symptom Score (COMPASS)‐31 and objective indices of ANSD obtained from heart rate variability analyses, ambulatory blood pressure (BP) monitoring, and CO 2 chemosensitivities and (2) describe the organ system ANSD, its relationship to PHOX2B genotype, and its consequences on quality of life (PedsQL) in children with CCHS.

Results

Thirty‐two PHOX2B mutation‐confirmed subjects (median [range] age 9.2 years (4.4; 18.0), 15 girls) were enrolled. COMPASS‐31 was assessed in 32 matched (sex and age, range: 4.3; 18.9 years) healthy controls. As compared to healthy controls, children with CCHS had increased vasomotor ( p = 0.001), secretomotor ( p = 0.021), gastrointestinal ( p = 0.002) and pupillomotor ( p = 0.028) scores and decreased orthostatic intolerance scores ( p = 0.050). There was no difference in overall COMPASS‐31 score between CCHS and controls ( p = 0.083). However, in CCHS, overall COMPASS‐31 scores correlated with high frequencies (HF) normalized (cardiac parasympathetic modulation: R = −0.53; p = 0.002), low frequencies (LF)/HF ratio (R = 0.56; p < 0.001), and both systolic and diastolic nighttime BP dipping (R = 0.45, p = 0.012 and R = 0.40, p = 0.028, respectively). No significant relationships between COMPASS‐31 scores and chemosensitivity testing, PedsQL scores, or PHOX2B genotype were identified.

Conclusions

COMPASS‐31 identified some aspects of CCHS‐related ANSD, and scores correlate with objective ANS function measures, supporting the potential utility of COMPASS‐31 in CCHS.

Subjects

MeSH terms (MEDLINE)

Sleep Apnea, CentralHypoventilationAutonomic Nervous System DiseasesAutonomic Nervous SystemHumansFemaleMaleChildHomeodomain ProteinsProspective StudiesChild, PreschoolAdolescentTranscription FactorsHeart RateQuality of LifeReproducibility of ResultsBlood Pressure Monitoring, AmbulatoryCase-Control StudiesMutation

Author keywords

CO2 chemosensitivityHolter electrocardiogramautonomic nervous system dysfunction

Substances

NBPhox proteinHomeodomain ProteinsTranscription Factors

Authors and institutions

  • Service de Physiologie Pédiatrique -Centre du Sommeil - CRMR Hypoventilations alvéolaires rares, AP-HP, Hôpital Robert Debré, INSERM NeuroDiderot, Université de Paris Cité, Paris, France.
  • Service de Physiologie Pédiatrique, AP-HP, Hôpital Robert Debré, Paris, France.
  • Département de Génétique, AP-HP, Hôpital Robert Debré, Paris, France.
  • Division of Autonomic Medicine, Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago and Stanley Manne Children's Research Institute, Chicago, Illinois, USA.
  • Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Funding

  • The authors received no specific funding for this study.

Cite

APA

Dudoignon, B., Bokov, P., Benterki, F., Couque, N., Rand, C. M., Weese-Mayer, D. E., & Delclaux, C. (2025). Reliability of Composite Autonomic Symptom Score (COMPASS)‐31 in Congenital Central Hypoventilation Syndrome. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71072

Vancouver

Dudoignon B, Bokov P, Benterki F, Couque N, Rand CM, Weese-Mayer DE, et al. Reliability of Composite Autonomic Symptom Score (COMPASS)‐31 in Congenital Central Hypoventilation Syndrome. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71072

BibTeX
@article{Dudoignon2025,
  author = {Dudoignon, Benjamin and Bokov, Plamen and Benterki, Fatima and Couque, Nathalie and Rand, Casey M and Weese-Mayer, Debra E and Delclaux, Christophe},
  title = {Reliability of Composite Autonomic Symptom Score (COMPASS)‐31 in Congenital Central Hypoventilation Syndrome},
  journal = {Pediatric Pulmonology},
  year = {2025},
  doi = {10.1002/ppul.71072}
}
Start for free →